Cargando…

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

BACKGROUND: Respiratory syncytial virus (RSV) is responsible for most respiratory tract infections and hospitalizations in infants and represents a significant economic burden for public health. The development of a safe, effective, and affordable vaccine is a priority for the WHO. METHODS: We condu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abarca, Katia, Rey-Jurado, Emma, Muñoz-Durango, Natalia, Vázquez, Yaneisi, Soto, Jorge A., Gálvez, Nicolás M.S., Valdés-Ferrada, Javier, Iturriaga, Carolina, Urzúa, Marcela, Borzutzky, Arturo, Cerda, Jaime, Villarroel, Luis, Madrid, Victoria, González, Pablo A., González-Aramundiz, José V., Bueno, Susan M., Kalergis, Alexis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548429/ https://www.ncbi.nlm.nih.gov/pubmed/33073219 http://dx.doi.org/10.1016/j.eclinm.2020.100517

Ejemplares similares

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Peña, Marcela, et al.
Publicado: (2020)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
por: Vázquez, Yaneisi, et al.
Publicado: (2019)

TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2017)

Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients
por: Valdés-Ferrada, Javier, et al.
Publicado: (2020)

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
por: Gálvez, Nicolás MS, et al.
Publicado: (2022)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021)

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial
por: Abarca, Katia, et al.
Publicado: (2022)

BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus
por: Soto, Jorge A., et al.
Publicado: (2022)

Contribution of autophagy to antiviral immunity
por: Rey-Jurado, Emma, et al.
Publicado: (2015)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution
por: Rey-Jurado, Emma, et al.
Publicado: (2018)

Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice
por: Soto, Jorge A., et al.
Publicado: (2021)

Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
por: Diethelm-Varela, Benjamín, et al.
Publicado: (2023)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection
por: Silva, Pedro H., et al.
Publicado: (2022)

Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)

The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination
por: Valdivia-Olivares, Rayen Yanara, et al.
Publicado: (2021)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2022)

Contribution of hypoxia inducible factor-1 during viral infections
por: Reyes, Antonia, et al.
Publicado: (2020)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells
por: Tognarelli, Eduardo I., et al.
Publicado: (2019)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus
por: Acevedo, Orlando A., et al.
Publicado: (2019)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Single Nucleotide Polymorphisms in Apolipoprotein B, Apolipoprotein E, and Methylenetetrahydrofolate Reductase Are Associated With Serum Lipid Levels in Northern Chilean Subjects. A Pilot Study
por: Gálvez, Anita S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l61uuv57c8v9gp7ttrcn2q8kgk